Irelli, A.; Ceriello, L.; Patruno, L.V.; Tessitore, A.; Alesse, E.; Cannita, K.; Fabiani, D.
Takotsubo Syndrome during Pertuzumab and Trastuzumab Therapy for HER2-Positive Metastatic Breast Cancer. Biomedicines 2024, 12, 179.
https://doi.org/10.3390/biomedicines12010179
AMA Style
Irelli A, Ceriello L, Patruno LV, Tessitore A, Alesse E, Cannita K, Fabiani D.
Takotsubo Syndrome during Pertuzumab and Trastuzumab Therapy for HER2-Positive Metastatic Breast Cancer. Biomedicines. 2024; 12(1):179.
https://doi.org/10.3390/biomedicines12010179
Chicago/Turabian Style
Irelli, Azzurra, Laura Ceriello, Leonardo Valerio Patruno, Alessandra Tessitore, Edoardo Alesse, Katia Cannita, and Donatello Fabiani.
2024. "Takotsubo Syndrome during Pertuzumab and Trastuzumab Therapy for HER2-Positive Metastatic Breast Cancer" Biomedicines 12, no. 1: 179.
https://doi.org/10.3390/biomedicines12010179
APA Style
Irelli, A., Ceriello, L., Patruno, L. V., Tessitore, A., Alesse, E., Cannita, K., & Fabiani, D.
(2024). Takotsubo Syndrome during Pertuzumab and Trastuzumab Therapy for HER2-Positive Metastatic Breast Cancer. Biomedicines, 12(1), 179.
https://doi.org/10.3390/biomedicines12010179